Alyeska Investment Group, L.P.

Position in LNTH — Lantheus Holdings, Inc.

CIK 1453072 CHICAGO, IL

Back to LNTH Full portfolio

Position in LNTH

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$23,175,891

+$13,470,721 QoQ

Shares Held

305,549

+95.2% QoQ

Ownership

0.469%

of shares outstanding

% of Portfolio

0.07%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2022

5 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in LNTH Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Alyeska Investment Group, L.P. holds $190,720,824 across 3 Drug Manufacturers - Specialty & Generic names. LNTH ranks #2 (12.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TEVA	Teva Pharmaceutical Industries Ltd	5,519,030	$166,233,183
2	LNTH	Lantheus Holdings, Inc. This page	305,549	$23,175,891
3	BIOA	BioAge Labs, Inc.	75,000	$1,311,750

All Filings in LNTH

Export CSV

5 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$23,175,891	305,549	+95.2%	Shares	Sole	2026-05-15
2023-12-31	$9,705,170	156,535	+25.2%	Shares	Sole	2024-02-14
2023-09-30	$8,685,000	125,000	0.0%	Shares	Sole	2023-11-14
2023-06-30	$10,490,000	125,000	+544.2%	Shares	Sole	2023-08-14
2022-12-31	$988,827	19,404	—	Shares	Sole	2023-02-14
No filing history on record for this holder in this stock.